Rotraxate
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171961This classification denotes an anti-ulcer agent with the molecular formula C17H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KRN50N3Y2T, chemically known as benzenepropanoic acid, 4-((4-(aminomethyl)cyclohexyl)carbonyl)-, trans- but generally known as rotraxate, which bears US NIH Compound Identifier 65829. European Medicines Agency schedules Rotraxate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10393MIG. The term ROTRAXATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). ROTRAXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rotraxate under HS 29225000 and SITC 51467. As of Q4 2014, ROTRAXATE remains the US FDA Preferred Term for this commodity. Rotraxate bears US NLM identifiers UMLS ID C2699113 and NCI Concept Code C76490. SMILES: O=C(C1CCC(CC1)CN)C1CCC(CC1)CCC(=O)O.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.